GA4GH

RARE-X Releases New Report that Uncovers Large Number of Previously Uncounted Rare Diseases

Retrieved on: 
Tuesday, June 7, 2022
Research, Public Policy, Government, Philanthropy, Biotechnology, White House, Federal Government, General Health, Pharmaceutical, Health, Foundation, Science, Acceleration, Congress, DrugBank, Lists of diseases, Food, CEO, Alexion Pharmaceuticals, Disease, Awareness, OMIM, Organization, Knowledge, Degenerative disease, Patient, Risk, Global Alliance for Genomics and Health, OOD, Radar, The Monarch Initiative, GA4GH, Genomics, Medical device, Pharmaceutical industry, Health

Ensuring that the true magnitude of rare diseases is understood is critical, said Charlene Son Rigby, CEO of RARE-X.

Key Points: 
  • Ensuring that the true magnitude of rare diseases is understood is critical, said Charlene Son Rigby, CEO of RARE-X.
  • If patient communities, researchers, drug developers, and policymakers are to address rare diseases, its essential to understand the magnitude of the problem.
  • The study authors developed a reproducible methodology to identify the accurate number of rare diseases.
  • The analysis showed that there are as many as 10,867 rare diseases, including genetic and non-genetic diseases.

Hammerspace Joins Global Alliance for Genomics and Health

Retrieved on: 
Tuesday, May 3, 2022
Global Alliance for Genomics and Health, Information technology, Data management, Medicine, HPC, Genomics, Organization, Microscopy, Precision medicine, GA4GH, Global Alliance, CEO, Technology, Research, SAN, Framework, Medical device, Cryptocurrency, Hammerspace, Health

BOSTON and SAN MATEO, Calif., May 3, 2022 /PRNewswire-PRWeb/ -- Hammerspace, the pioneer of the Global Data Environment, today announced that it has joined the Global Alliance for Genomics and Health. Hammerspace will partner with more than 600 of the world's leading healthcare, research, patient advocacy, life science and information technology organizations to create the frameworks and standards for sharing genomic and health-related data.

Key Points: 
  • Hammerspace has joined the Global Alliance for Genomics and Health, partnering with more than 600 of the world's leading healthcare, research, patient advocacy, life science and information technology organizations to aid the sharing of genomic and health-related data.
  • BOSTON and SAN MATEO, Calif., May 3, 2022 /PRNewswire-PRWeb/ -- Hammerspace , the pioneer of the Global Data Environment, today announced that it has joined the Global Alliance for Genomics and Health .
  • Hammerspace is committed to working together with member organizations to help bring the vision of the Global Alliance for Genomics and Health to fruition.
  • The Global Alliance for Genomics and Health (GA4GH) is an international, nonprofit alliance formed in 2013 to accelerate the potential of research and medicine to advance human health.

$8.4 Bn CRISPR Markets - Global Forecasts from 2021 to 2026: Escalating R&D to Provide Opportunities Market Players - ResearchAndMarkets.com

Retrieved on: 
Tuesday, September 21, 2021
Biotechnology, Genetics, Health, CRISPR, CRISPR Therapeutics, Biotechnology, Shorthand, Therapy, Gene editing, Deletion, National Center for Biotechnology Information, Anti-transglutaminase antibodies, Collection, Genome, CAGR, DNA, Amyotrophic lateral sclerosis, Cancer, Patient, Global Alliance for Genomics and Health, Lists of diseases, Library, GA4GH, Agriculture, USDA, Risk, Plasmid, Genomics, Brassica, Technology, PerkinElmer, Global Alliance, Genetic engineering, ALS, Qiagen, Friedreich's ataxia, Research, Haemophilia, Birth, Investment, Industry, Pharmaceutical industry, Vaccine

The global CRISPR market is a growing with major investments from developed countries.

Key Points: 
  • The global CRISPR market is a growing with major investments from developed countries.
  • The growing need for drug research, the risk of congenital abnormalities, and late pregnancies resulting in birth problems are key factors driving the CRISPR market forward.
  • The escalating geriatric population, Changes in lifestyles, and investment in cutting-edge research technologies are also augmenting the market size.
  • A lot of research and development happening in the market is anticipated to boost the opportunities through the inclining market trends.